Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 4, 1997, Pages 1461-1464

  Robuschi, Maria ^b   Gambaro, Gabriella ^b   Sestini, Piersante ^a   Pieroni, Maria Grazia ^b   Refini, Rosa Metella ^b   Vaghi, Adriano ^b   Bianco, Sebastiano ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CROMOGLYCATE DISODIUM; FENOTEROL; IPRATROPIUM BROMIDE; NEDOCROMIL SODIUM; PLACEBO; PREDNISONE; SALBUTAMOL; THEOPHYLLINE;

ADULT; AIRWAY RESISTANCE; ARTICLE; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030945279     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.4.9105094     Document Type: Article

References (36)

1. Busse, W. W. 1994. Rationale and current approach to treating asthma. Ann. Intern. Med. 121:704-706.
2. Barnes, P. J. 1995. Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Clin. Exp. Allergy 25:771-787.
3. Scheffer, A. L., editor. 1995. Global strategy for asthma management and prevention. NHLBI/WHO Workshop report. National Institutes of Health, National Heart, Lung, and Blood Institute (Publication No. 95-3659).
4. Pearce, F. L., M. Al-Laith, L. Bosman, J. Brostoff, T. M. Cunniffe, K. C. Flint, B. N. Hudspith, Z. H. Jaffar, N. M. Johnson, T. A. Kasessinoff, H. Y. A. Lau, P. Y. Lee, K. B. P. Leung, W. L. Liu, and K. R. Tainsh. 1989. Effect of sodium cromoglycate and nedocromil sodium on histamine secretion from mast cells from various locations. Drugs 37(Suppl. 1):37-43.
5. Verleden, G. M., M. G. Belvisi, C. D. Stretton, and P. J. Barnes. 1991. Nedocromil sodium modulates nonadrenergic noncholinergic bronchoconstrictor nerves in guinea pig airways in vitro. Am. Rev. Respir. Dis. 143:114-118.
6. Altounyan, R. E. C., M. Cole, and T. B. Lee. 1986. Inhibition of sulphur-dioxide induced bronchoconstriction by nedocromil sodium and sodium cromoglycate in non-asthmatic atopic subjects. Eur. J. Respir. Dis. 69(Suppl. 147):274-276.
7. Richards, R., G. D. Phillips, and S. T. Holgate. 1987. Nedocromil sodium is more potent than sodium cromoglycate against AMP-induced bronchoconstriction in atopic asthmatic subjects. Clin. Exp. Allergy 19:285-291.
8. Crimi, N., P. Palermo, R. Olivieri, C. Vancheri, and R. Polosa. 1988. Comparative study of the effect of nedocromil sodium (4 mg) and sodium cromoglycate (10 mg) on adenosine-induced bronchoconstriction in asthmatic subjects. Clin. Allergy 18:367-374.
9. Dixon, C. M., and P. W. Ind. 1990. Inhaled sodium metabisulphite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br. J. Clin. Pharmacol. 30:371-376.
10. Marquette, C. H., M. Joseph, A. B. Tonnel, H. Vorng, P. Lassalle, A. Tsicopulos, and A. Capron. 1990. The abnormal in vitro response to aspirin of platelets from aspirin-sensitive asthmatics is inhibited after inhalation of nedocromil sodium but not of sodium cromoglycate. Br. J. Clin. Pharmacol. 29:525-531.
11. Basomba, A., A. Romar, A. Pelaez, I. G. Villalmanzo, and A. Campos. 1976. The effect of sodium cromoglycate in preventing aspirin-induced bronchospasm. Clin. Allergy 6:269-275.
12. Martelli, N. A., and G. Usandivaras. 1977. Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation. Thorax 32: 684-690.
13. Wuthric, B. 1980. Protective effect of ketotifen and disodium cromoglycate against bronchoconstriction induced by aspirin, benzoic acid or tartrazine in intolerant asthmatics. Respiration 37:224-231.
14. Pasargiklian, M., S. Bianco, L. Allegra, N. E. Moavero, G. Petrigni, and A. A. Grugni. 1977. Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. Respiration 34:79-91.
15. Zanon, P., I. Cerveri, C. Rampulla, M. C. Zoia, C. Brushci, and A. Rosi. 1983. Prevenzione farmacologica dell' asma indotta dall' inalazione di aspirina. Folia Allergol. Immunol. Clin. 30:102-109.
16. Bianco, S., M. Robuschi, and G. Petrigni. 1977. Aspirin induced tolerance in aspirin asthma detected by a new challenge test. IRCS J. Med. Sci. 5:129.
17. Grizzle, J. E. 1965. The two-period change-over design and its use in clinical trials. Biometrics 21:467-480.
18. Pearson, D. J., and V. J. Suarez-Mendez. 1990. Abnormal platelet hydrogen peroxide metabolism in aspirin hypersensitivity. Clin. Exp. Allergy 20:157-163.
19. Guez, S., N. Gualde, J. H. Bezian, and G. Cabanieu. 1992. In vitro study of platelets and circulating mononuclear cells of subjects presenting an intolerance to aspirin. Int. Arch. Allergy Immunol. 97: 223-236.
20. Nizankowska, E., G. Czerniawska-Mysik, and A. Szczeklik. 1986. Lack of effect of i.v. prostacyclin on aspirin-induced asthma. Eur. J. Respir. Dis. 69:363-368.
21. Juniper, E. F., P. A. Kiline, M. M. Morris, and F. E. Hargreave. 1987. Airway constriction by isocapnic hyperventilation of cold, dry air: comparison of magnitude and duration of action of protection by nedocromil sodium and sodium cromoglycate. Clin. Allergy 17:523-528.
22. Comis, A., E. A. Valletta, L. Sette, A. Andreoli, and A. L. Boner. 1993. Comparison of nedocromil sodium and sodium cromoglycate administered by pressurized aerosol, with and without a spacer device in exercise-induced asthma in children. Eur. Respir. J. 6:523-526.
23. Dixon, C. M. S., and P. J. Barnes. 1989. Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br. J. Clin. Pharmacol. 27:831-836.
24. 2 release from primate bronchoalveolar mast cells and comparison with rat peritoneal mast cells. J. Immunol. 137:3941-3945.
25. - channels by antiallergic drugs. Biochem. Biophys. Res. Commun. 188: 957-963.
26. Paulmichl, M., A. A. Norris, and D. K. Rainey. 1995. Role of chloride channel modulation in the mechanism of action of nedocromil sodium. Int. Arch. Allergy Immunol. 107:416.
27. Rocchiccioli, K. M. S., and P. A. Riley. 1989. Clinical pharmacology of nedocromil sodium. Drugs 37(Suppl. 1):123-126.
28. Barnes, P. J. 1993. Effect of nedocromil sodium on airway sensory nerves. J. Allergy Clin. Immunol. 92:182-186.
29. Szczeklik, A. 1990. The cyclooxygenase theory of aspirin-induced asthma. Eur. Respir. J. 3:588-593.
30. Lee, T. H. 1993. Mechanism of bronchospasm in aspirin-sensitive asthma. Am. Rev. Respir. Dis. 148:1442-1443.
31. Dahlén, B., M. Kumlin, D. J. Margolskee, C. Larsson, H. Blomqvist, V. C. Williams, O. Zettelström, and S. Dahlén. 1993. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur. Respir. J. 6:1018-1026.
32. 4 excretion in aspirin-sensitive asthma. Am. J. Respir. Crit. Care Med. 153:572-575.
33. Sladek, K., and A. Szczeklik. 1993. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur. Respir. J. 6:391-399.
34. Fischer, A. R., M. A. Rosenberg, C. M. Lilly, J. C. Callery, P. Rubin, J. Conn, M. V. White, Y. Igarashi, M. A. Kaliner, J. M. Drazen, and E. Israel. 1994. Direct evidence for a role of the mast cell in the nasal response to aspirin-sensitive asthma. J. Allergy Clin. Immunol. 94:1046-1056.
35. Okayama, Y., R. C. Benyon, P. H. Rees, M. A. Lowman, K. Hillier, and M. K. Church. 1992. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin. Exp. Allergy 22:401-409.
36. Bruijnzeel, P. L. B., R. A. J. Warringa, P. T. M. Kok, M. L. Hamelink, H. Kreukniet, and L. Koenderman. 1993. Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes. J. Allergy Clin. Immuunol. 92:159-164.